Literature DB >> 27659377

Paraneoplastic polymyositis presenting as a clinically occult breast cancer.

N Merali1, M Yousuff1, V Pronisceva1, A Poddar1.   

Abstract

Paraneoplastic syndrome affects less than 1% of cancer patients. Diagnosis of paraneoplastic syndrome with neurological presentation requires screening for an underlying malignancy, including a complete history, physical examination and imaging studies. Treatment often results in symptom stability, rather than improvement. Paraneoplastic polymyositis can precede or instantaneously occur at diagnosis or treatment of a primary tumour, while neurological symptoms can persist even following cancer treatment. We report a rare case of metaplastic breast carcinoma with an unusual presentation of paraneoplastic polymyositis.

Entities:  

Keywords:  Breast cancer; Diagnosis; Metaplastic carcinoma; Neurology; Paraneoplastic syndrome

Mesh:

Year:  2016        PMID: 27659377      PMCID: PMC5392829          DOI: 10.1308/rcsann.2016.0301

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  13 in total

1.  Dermatosis as the Initial Manifestation of Malignant Breast Tumors: Retrospective Analysis of 4 Cases.

Authors:  Ying-Jie Song; Yun-Fei Wu; Tao Fan
Journal:  Breast Care (Basel)       Date:  2010-06-16       Impact factor: 2.860

2.  Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study.

Authors:  R Buchbinder; A Forbes; S Hall; X Dennett; G Giles
Journal:  Ann Intern Med       Date:  2001-06-19       Impact factor: 25.391

Review 3.  Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature.

Authors:  Alessandro M Minisini; Giada Pauletto; Paolo Bergonzi; Gianpiero Fasola
Journal:  Breast Cancer Res Treat       Date:  2006-11-23       Impact factor: 4.872

Review 4.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

5.  Breast carcinoma in patients with dermatomyositis: a retrospective analysis of eight cases.

Authors:  Chun-Nan Yeh; Shin-Cheh Chen; Tsann-Long Hwang; Miin-Fu Chen; Chuang-Chi Liaw; Heng-Leong Chan
Journal:  Chang Gung Med J       Date:  2002-06

Review 6.  Paraneoplastic neurologic syndrome associated with occult breast cancer: a case report and review of literature.

Authors:  Ramin Altaha; Jame Abraham
Journal:  Breast J       Date:  2003 Sep-Oct       Impact factor: 2.431

Review 7.  Managing paraneoplastic neurological disorders.

Authors:  Janet W de Beukelaar; Peter A Sillevis Smitt
Journal:  Oncologist       Date:  2006-03

8.  Tubular carcinoma of the breast: further evidence to support its excellent prognosis.

Authors:  Emad A Rakha; Andrew H S Lee; Andrew J Evans; Sindhu Menon; Nancy Y Assad; Zsolt Hodi; Douglas Macmillan; Roger W Blamey; Ian O Ellis
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

9.  Treatment options for metaplastic breast cancer.

Authors:  Dhruvil R Shah; Warren H Tseng; Steve R Martinez
Journal:  ISRN Oncol       Date:  2012-06-21

10.  Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.

Authors:  Alan Christie; Neil McKay; Fiona Nussey
Journal:  Gynecol Oncol Case Rep       Date:  2013-07-16
View more
  2 in total

1.  Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis: A case report.

Authors:  Lulu Liu; Jingjing Zhang; Mingtai Chen; Saisai Ren; Haihui Liu; Hao Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

2.  A Unique Case of Muscle-Invasive Metastatic Breast Cancer Mimicking Myositis.

Authors:  Janelle Gyorffy; Samuel M Philbrick; Adrian R Bersabe; Richard J Upton; Derek A Mathis; Austin Peters; Alexander Brown
Journal:  Case Rep Oncol Med       Date:  2017-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.